Tumor burden (tumor volume) was also significantly lower (p < 0.001) in wild-type mice implanted with the Kindlin-2-deficient cells as compared with their control counterparts (Figure 5D, compare black graph to red graph). This evidence concerns the gene FERMT2 and neoplasm.